Uteron Pharma : Research for woman future Uteron Pharma : Research for woman future Uteron Pharma : Research for woman future
Uteron Pharma : Research for woman future

2012/05/2 : Uteron Pharma is contemplating a public offering to finance the (...)

Read more


2012/04/24 : Professor Jean-Michel Foidart has been awarded the Bologne-Lemaire (...)

Read more


2012/03/30 : Uteron Pharma successfully raises 14 million EUR

Read more



Uteron Pharma : Research for woman future

About us

Pioneers in Woman Healthcare

At Uteron pharma we are committed to enabling (cutting-edge scientific) research that is driven by the women’s needs.

Our mission is to help improve overall healthcare and everyday lives of women. We focus on providing high value products relating to (i) Contraception and fertility (ii) Menopause and osteoporosis (iii) Utero-vaginal sphere and (iv) Female cancer

Our diversified development portfolio includes a new generation of oral contraceptives based on natural hormones, a hormonal intra-uterine device, treatments for persistent vaginal infections and a new generation of tests that will significantly increase in-vitro fertilisation success rates. Based on a silicone based technology platform, Uteron also develops sustained or controlled release devices for well known hormones.

It is the intention of Uteron to market its products worldwide through a network of partners as soon as its products have been approved by the appropriate health authorities. Uteron, headquartered in Liege (Belgium), is a privately-owned group of companies.





© 2011 Uteron Pharma - Legal - Privacy policy Designed and Powered by Lusis Communication

Company

Products

Production

Market

Newsroom

Uteron Pharma : Research for woman future